Doug Carsten is the co-head of McDermott’s life sciences industry practice and focuses on complex patent litigation disputes.
In this Q&A, Doug shares what he enjoys most about being a trial lawyer, his go-to advice for...more
McDermott is pleased to bring our Life Sciences Boot Camp for In-House Counsel back to the Bay Area!
Amid turbulent economic forces, life sciences companies continue to grapple with increasingly complex legal and business...more
3/21/2023
/ Acquisitions ,
Compliance ,
Continuing Legal Education ,
Corporate Counsel ,
Enforcement ,
Events ,
Food and Drug Administration (FDA) ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
Life Sciences ,
Medical Devices ,
Mergers ,
NAD ,
Pharmaceutical Industry ,
Prescription Drugs
The past year brought many developments in the life sciences patent legal space. Three decisions in particular hold potential ramifications for drug makers and patent holders in 2023. This year, the Supreme Court of the...more
We are committed to providing insightful commentary on IP developments from around the world to our Japanese clients. In light of that effort, we are continuing our free monthly webinar series, McDermott IP Focus. During...more
2/2/2023
/ Continuing Legal Education ,
Exclusivity ,
Generic Drugs ,
Life Sciences ,
Orange Book ,
Orphan Drugs ,
Patent Infringement ,
Patent Litigation ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prescription Drugs ,
Webinars